<> <http://www.w3.org/2000/01/rdf-schema#comment> "The repository administrator has not yet configured an RDF license."^^<http://www.w3.org/2001/XMLSchema#string> .
<> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/60502> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/AcademicArticle> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/title> "PEG-INF ALFA-2B (ALGERON)  VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/ontology/bibo/abstract> "Surunkali delta gepatit (SDG) – gepatit B virusi (HBV) bilan birgalikda yuquvchi kasallik bo‘lib, jigar to‘qimasida og‘ir yallig‘lanish va fibroz jarayonlarini keltirib chiqaradigan kasallikdir. SDG dunyo bo‘yicha gepatitlar orasida eng xavfli va davolashda murakkab bo‘lgan turlaridan biri hisoblanadi."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/date> "2025-11-20" .
<https://arxiv.universalpublishings.com/id/org/ext-dce91bc34ec9a52b0fb2d7899759e2d8> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
<https://arxiv.universalpublishings.com/id/org/ext-dce91bc34ec9a52b0fb2d7899759e2d8> <http://xmlns.com/foaf/0.1/name> "\"Research Science and Innovation house\" LLC"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/publisher> <https://arxiv.universalpublishings.com/id/org/ext-dce91bc34ec9a52b0fb2d7899759e2d8> .
<https://arxiv.universalpublishings.com/id/publication/ext-b6530cc07ed9d05480e619db77ea5cb1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Collection> .
<https://arxiv.universalpublishings.com/id/publication/ext-b6530cc07ed9d05480e619db77ea5cb1> <http://xmlns.com/foaf/0.1/name> "Journal of Universal Science Research"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/publication/ext-b6530cc07ed9d05480e619db77ea5cb1> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/ontology/bibo/status> <http://purl.org/ontology/bibo/status/published> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/60502#authors> .
<https://arxiv.universalpublishings.com/id/eprint/60502#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_1> <https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> .
<https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> <http://xmlns.com/foaf/0.1/givenName> "Raimov Kamol"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> <http://xmlns.com/foaf/0.1/familyName> "Eshmo’minovich"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-481a30d0abe6f40402cf7c6cd05f4aab> <http://xmlns.com/foaf/0.1/name> "Raimov Kamol Eshmo’minovich"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/EPrint> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/ArticleEPrint> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/repository> .
<https://arxiv.universalpublishings.com/id/eprint/60502> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://arxiv.universalpublishings.com/id/eprint/60502/> .
<https://arxiv.universalpublishings.com/id/eprint/60502/> <http://purl.org/dc/elements/1.1/title> "HTML Summary of #60502 \n\nPEG-INF ALFA-2B (ALGERON)  VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH\n\n" .
<https://arxiv.universalpublishings.com/id/eprint/60502/> <http://purl.org/dc/elements/1.1/format> "text/html" .
<https://arxiv.universalpublishings.com/id/eprint/60502/> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/60502> .